These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9544765)

  • 1. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
    Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC
    JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
    Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
    JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
    Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
    JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
    Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
    J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 mutations in African Americans.
    Panguluri RC; Brody LC; Modali R; Utley K; Adams-Campbell L; Day AA; Whitfield-Broome C; Dunston GM
    Hum Genet; 1999; 105(1-2):28-31. PubMed ID: 10480351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
    Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
    JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
    Malone KE; Daling JR; Doody DR; Hsu L; Bernstein L; Coates RJ; Marchbanks PA; Simon MS; McDonald JA; Norman SA; Strom BL; Burkman RT; Ursin G; Deapen D; Weiss LK; Folger S; Madeoy JJ; Friedrichsen DM; Suter NM; Humphrey MC; Spirtas R; Ostrander EA
    Cancer Res; 2006 Aug; 66(16):8297-308. PubMed ID: 16912212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
    Zhang B; Fackenthal JD; Niu Q; Huo D; Sveen WE; DeMarco T; Adebamowo CA; Ogundiran T; Olopade OI
    Fam Cancer; 2009; 8(1):15-22. PubMed ID: 18679828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
    Meindl A;
    Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
    Unger MA; Nathanson KL; Calzone K; Antin-Ozerkis D; Shih HA; Martin AM; Lenoir GM; Mazoyer S; Weber BL
    Am J Hum Genet; 2000 Oct; 67(4):841-50. PubMed ID: 10978226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer.
    Anton-Culver H; Cohen PF; Gildea ME; Ziogas A
    Eur J Cancer; 2000 Jun; 36(10):1200-8. PubMed ID: 10882857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
    Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
    Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.
    Palmieri G; Palomba G; Cossu A; Pisano M; Dedola MF; Sarobba MG; Farris A; Olmeo N; Contu A; Pasca A; Satta MP; Persico I; Carboni AA; Cossu-Rocca P; Contini M; Mangion J; Stratton MR; Tanda F
    Ann Oncol; 2002 Dec; 13(12):1899-907. PubMed ID: 12453858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
    Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
    Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of BRCA1 gene in African-American patients with breast cancer.
    Shen D; Wu Y; Subbarao M; Bhat H; Chillar R; Vadgama JV
    J Natl Med Assoc; 2000 Jan; 92(1):29-35. PubMed ID: 10800284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.